Inhibitor Therapeutics (INTI) Financial Statements

Inhibitor Therapeutics's market cap is currently $7.32M. The company's EPS TTM is $-0.019; its P/E ratio is -2.41; Inhibitor Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.